Skip to main content
Caplight Logo









Balmes Transplantation

Balmes Transplantation

Private
MarseilleHealthcare & Life Scienceshttps://balmestransplantation.com

Company Overview

Balmes Transplantation was a pharmaceutical company that developed drug candidates for reducing ischemia-reperfusion injuries in organ transplantation.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

IRIischemia-reperfusion injuryorgan transplantationbiotech startupbiotechdrug discoverypharma R&Dpharmacological treatmentorgan preservationkidney transplantationpreclinical developmentorgan transplant techsmall moleculetherapeutic solutiontranslational medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Balmes Transplantation Comparables

Compare Balmes Transplantation with similar companies based on industry and business-model similarity.

Balmes Transplantation comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
cellvie
82%
Morningside
70%
Ischemix, Inc.
69%
View all Comparables

Balmes Transplantation Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Balmes Transplantation Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Balmes Transplantation Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Balmes Transplantation's valuation, stock price, and market status.

Firmographic Details

HeadquartersMarseille
Year Founded2015
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?